The public registers hold a second record for Siegfried Hameln. The fuller profile, with 94 active US DMFs and 40 valid CEPs, is at Siegfried. Figures on this page cover only this record.
Siegfried Hameln is a finished-dose manufacturer based in Germany. It appears in 14 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with MINSA (CR), ARCSA (EC) and UZPHARM (UZ). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and EMA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 1 September 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| HAMELN, Germany | Not on file |
| Lower Saxony, Germany | Not on file |
| Germany, Germany | 3002807877 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 6 | None |
| ARCSA (EC) | 2 | None |
| UZPHARM (UZ) | 2 | None |
| NAFDAC (NG) | 1 | None |
| INVIMA (CO) | 1 | None |
| JFDA (JO) | 1 | None |
| ZLG (DE) | None | 8 |
| ANVISA (Brazil) | None | 8 |
| EMA | None | 2 |
| MFDS (Korea) | None | 2 |
| EAEU_EEC | None | 1 |
Choose your molecules and target markets. Siegfried Hameln comes back tiered against every other supplier able to file there.
Start for free